Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) will be giving a presentation at the Cowen & Co. 30th Annual Healthcare Event. The company’s Senior VP and Chief Scientific Officer, Dominic P. Behan, Ph.D., will host their presentation.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Arena is scheduled to deliver an overview of the company which will include clinical development and research programs on March 10th at 8:45am (EST). The conference is being held in Boston, Mass. at the Boston Marriott Copley Place. A webcast of the presentation will be made available through the investor relations section of the company’s website.
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
